Supernus Pharmaceuticals
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Supernus Pharmaceuticals's balance sheet done over the years? Its assets were worth $1,277,673,000 last year, which is less than in the previous period. 28% of Supernus Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $356,157,000, which means an decrease by -56% compared compared to last year.
Debt to Assets
| 2014 | 137508000 | 66.15M | 48.11% |
|---|---|---|---|
| 2015 | 188730000 | 69.85M | 37.01% |
| 2016 | 309568000 | 117.81M | 38.06% |
| 2017 | 424464000 | 156.98M | 36.98% |
| 2018 | 977811000 | 524.78M | 53.67% |
| 2019 | 1160282000 | 564.85M | 48.68% |
| 2020 | 1504102000 | 759.24M | 50.48% |
| 2021 | 1689152000 | 873.30M | 51.7% |
| 2022 | 1702508000 | 816.30M | 47.95% |
| 2023 | 1277673000 | 356.15M | 27.88% |
SUPN Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 75.05M | 93.12M | 203.43M | 288.64M | 181.38M | 192.24M | 100.30M | 90.12M | 62.19M | 74.33M |
Short term investments | 179.82M | 368.21M | 136.24M | 133.89M | 165.69M | 163.77M | 39.73M | 23.72M | 28.03M | 37.94M |
Net receivables | 144.15M | 165.49M | 148.93M | 140.87M | 87.33M | 102.92M | 65.58M | 41.52M | 25.90M | 17.27M |
Inventory | 77.40M | 91.54M | 85.95M | 48.32M | 26.62M | 25.65M | 16.30M | 16.80M | 12.58M | 13.44M |
Other current assets | 16.67M | 15.77M | 27.01M | 18.68M | 11.61M | 8.88M | 13.04M | 2.95M | 5.26M | 7.52M |
Total current assets | 493.11M | 734.15M | 601.59M | 630.41M | 472.64M | 493.48M | 228.45M | 151.40M | 105.97M | 108.89M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 42.52M | 15.17M | 16.95M | 37.82M | 38.34M | 4.09M | 5.12M | 4.34M | 3.87M | 2.44M |
Goodwill | 117.01M | 117.01M | 117.51M | 77.91M | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 599.88M | 702.46M | 784.69M | 442.25M | 24.84M | 31.36M | 36.01M | 16.49M | 976K | 5.43M |
Long term investments | 16.61M | 93.89M | 119.16M | 350.35M | 591.77M | 418.79M | 133.63M | 75.41M | 55.00M | 19.81M |
Other non-current assets | 8.51M | -10.00M | -36.12M | 8.03M | 615K | 380K | 389K | 20.19M | 391K | 6.35M |
Total non-current assets | 784.56M | 968.35M | 1.08B | 873.68M | 687.63M | 484.32M | 196.01M | 158.16M | 82.75M | 28.61M |
Total assets | 1.27B | 1.70B | 1.68B | 1.50B | 1.16B | 977.81M | 424.46M | 309.56M | 188.73M | 137.50M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 49.80M | 126.24M | 122.43M | 144.37M | -2.18M | 287K | 209K | 176K | 143K |
Short term debt | 8.33M | 401.96M | 6.47M | 3.76M | 2.82M | 2.18M | 4.28M | 69.37M | -17.13M | 0 |
Total current liabilities | 290.19M | 687.95M | 315.37M | 245.10M | 160.58M | 161.35M | 123M | 80.74M | 56.09M | 27.49M |
| Non-current liabilities: | ||||||||||
Long term debt | 33.19M | 35.99M | 420.55M | 390.33M | 375.61M | 329.46M | 22.25M | 4.16M | 7.08M | 26.94M |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 7.80M | 42.53M | 52.01M | 88.59M | 28.65M | 33.97M | 10.57M | 31.29M | 35.21M | 10.44M |
Total non-current liabilities | 65.96M | 128.34M | 557.92M | 514.13M | 404.26M | 363.43M | 33.98M | 37.07M | 13.75M | 38.66M |
Total liabilities | 356.15M | 816.30M | 873.30M | 759.24M | 564.85M | 524.78M | 156.98M | 117.81M | 69.85M | 66.15M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |